UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors

AIDS (London), 2014-03, Vol.28 (6), p.813-819

2014

Volltextzugriff (PDF)

Transmission networks of drug resistance acquired in primary/early stage HIV infection

AIDS (London), 2008-11, Vol.22 (18), p.2509-2515

2008

Volltextzugriff (PDF)

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline

AIDS (London), 2013-03, Vol.27 (6), p.879-887

2013

Volltextzugriff (PDF)

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

AIDS (London), 2003-01, Vol.17 (1), p.F1-F5

2003

Volltextzugriff (PDF)

In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.751-756

2012

Volltextzugriff (PDF)

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.600-607

2011

Volltextzugriff (PDF)

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4257-4267

2012

Volltextzugriff (PDF)

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4681-4688

2013

Volltextzugriff (PDF)

Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1670-1672

2009

Volltextzugriff (PDF)

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine

Antimicrobial Agents and Chemotherapy, 2007-11, Vol.51 (11), p.3861-3869

2007

Volltextzugriff (PDF)

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2878-2885

2010

Volltextzugriff (PDF)

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.708-715

2009

Volltextzugriff (PDF)

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2087-2094

2002

Volltextzugriff (PDF)

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1683-1685

2009

Volltextzugriff (PDF)

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Journal of medical virology, 2011-05, Vol.83 (5), p.751-759

2011

Volltextzugriff (PDF)

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2346-2349

2011

Volltextzugriff (PDF)

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection

AIDS (London), 2004-08, Vol.18 (12), p.1653-1660

2004

Volltextzugriff (PDF)

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

Antiviral chemistry & chemotherapy, 2004-10, Vol.15 (5), p.255-259

2004

Volltextzugriff (PDF)

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors

Journal of antimicrobial chemotherapy, 2012-04, Vol.67 (4), p.988-994

2012

Volltextzugriff (PDF)

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

Journal of acquired immune deficiency syndromes (1999), 2004-12, Vol.37 (5), p.1627-1631

2004

Volltextzugriff (PDF)

Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfection

AIDS research and human retroviruses, 2008-07, Vol.24 (7), p.995-1002

2008

Volltextzugriff (PDF)

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes

Antiviral research, 2010-09, Vol.87 (3), p.367-372, Article 367

2010

Volltextzugriff (PDF)

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

AIDS (London), 2006, Vol.20 (9), p.1211-1215

2006

Volltextzugriff (PDF)

High rates of forward transmission events after acute/early HIV-1 infection. Commentary

The Journal of infectious diseases, 2007, Vol.195 (7)

2007

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaViral Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(4)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Resistance mutations against dolutegravir in HIV integrase impair the emergence of resistance against reverse transcriptase inhibitors

Transmission networks of drug resistance acquired in primary/early stage HIV infection

Distinct resistance patterns to etravirine and rilpivirine in viruses containing nonnucleoside reverse transcriptase inhibitor mutations at baseline

A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors

In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors

Diminished representation of HIV-1 variants containing select drug resistance-conferring mutations in primary HIV-1 infection

Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfection

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

High rates of forward transmission events after acute/early HIV-1 infection. Commentary

Aktive Filter

Suchergebnisse filtern